Literature DB >> 7294510

Severe pulmonary involvement in mixed connective tissue disease.

J P Wiener-Kronish, A M Solinger, M L Warnock, A Churg, N Ordonez, J A Golden.   

Abstract

Pulmonary involvement in mixed connective tissue disease has been considered a benign manifestation that is easily treated with corticosteroids. We followed 5 patients who had mixed connective tissue disease and severe, rapidly progressive, lung disease. Two types of lung disease were found, interstitial lung disease and pulmonary hypertension. Histologic sections from our patients were compared with sections from patients who had interstitial lung disease and systemic lupus erythematosus or pulmonary hypertension and scleroderma. Although clinical presentations were similar, the immunofluorescent and electron microscopic findings for interstitial lung disease were somewhat different in patients with systemic lupus erythematosus. Histologic findings for pulmonary hypertension appeared different in patients with mixed connective tissue disease and patients with scleroderma. For patients with either type of lung disease, corticosteroid therapy proved inadequate, but nearly cytotoxic therapy may be beneficial.

Entities:  

Mesh:

Year:  1981        PMID: 7294510     DOI: 10.1164/arrd.1981.124.4.499

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  15 in total

Review 1.  'Overlap' syndromes.

Authors:  R Cervera; M A Khamashta; G R Hughes
Journal:  Ann Rheum Dis       Date:  1990-11       Impact factor: 19.103

Review 2.  Cardiac involvement in systemic autoimmune diseases.

Authors:  Piersandro Riboldi; Maria Gerosa; Cristina Luzzana; Luca Catelli
Journal:  Clin Rev Allergy Immunol       Date:  2002-12       Impact factor: 8.667

3.  Pulmonary hypertension in connective tissue disease.

Authors:  M Demedts
Journal:  Clin Rheumatol       Date:  1990-03       Impact factor: 2.980

4.  Pulmonary arterial hypertension in mixed connective tissue disease: successful treatment with Iloprost.

Authors:  Judit Végh; Györgyike Soós; István Csipõ; Nóra Demeter; Thomas Ben; Balázs Dezsõ; Margit Zeher; Katalin Dévényi; János Gaál; Gyula Szegedi; Edit Bodolay
Journal:  Rheumatol Int       Date:  2005-07-12       Impact factor: 2.631

5.  Circulating lupus type anticoagulant and pulmonary hypertension associated with mixed connective tissue disease.

Authors:  P Hainaut; E Lavenne; J M Magy; E G Lebacq
Journal:  Clin Rheumatol       Date:  1986-01       Impact factor: 2.980

6.  Acute systemic lupus erythematosus with fatal pneumonitis and disseminated intravascular coagulation.

Authors:  M Chellingsworth; D G Scott
Journal:  Ann Rheum Dis       Date:  1985-01       Impact factor: 19.103

Review 7.  Pulmonary manifestations of the rheumatic diseases.

Authors:  D W Boulware; D N Weissman; N J Doll
Journal:  Clin Rev Allergy       Date:  1985-05

8.  Decreased nailfold capillary density in Raynaud's phenomenon: a reflection of immunologically mediated local and systemic vascular disease?

Authors:  P M Houtman; C G Kallenberg; A A Wouda; T H The
Journal:  Ann Rheum Dis       Date:  1985-09       Impact factor: 19.103

9.  Mixed connective tissue disease with fatal pulmonary hypertension and a review of literature.

Authors:  N Ueda; K Mimura; H Maeda; T Sugiyama; T Kado; K Kobayashi; H Fukuzaki
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1984

10.  Severe Pulmonary Hypertension in Primary Sjögren's Syndrome.

Authors:  Ji-An Hwang; Tae-Hyun Yang; Ji-Young Lee; Dong-Wan Koo; In Suk Choi; Sun-Young Cho; Min-Sung Kim
Journal:  Korean Circ J       Date:  2013-07-31       Impact factor: 3.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.